CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells

The American Journal of Pathology - Tập 156 - Trang 7-14 - 2000
Uwe Schönbeck1, François Mach1, Galina K. Sukhova1, Michael Herman1, Pierre Graber2, Marilyn R. Kehry3, Peter Libby1
1Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2Ares Serono, Geneva, Switzerland
3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut

Tài liệu tham khảo

Wilcox, 1989, Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque, Proc Natl Acad Sci USA, 86, 2839, 10.1073/pnas.86.8.2839 Fuster, 1992, The pathogenesis of coronary artery disease and the acute coronary syndromes, N Engl J Med, 326, 242, 10.1056/NEJM199201233260406 Davies, 1985, Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina, Br Heart J, 53, 363, 10.1136/hrt.53.4.363 Nemerson, 1988, Tissue factor and hemostasis, Blood, 71, 1, 10.1182/blood.V71.1.1.1 Edgington, 1991, The structutal biology of expression and function of tissue factor, Thromb Haemost, 66, 67, 10.1055/s-0038-1646375 Mueller, 1998, Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis, J Clin Invest, 101, 1372, 10.1172/JCI930 Ott, 1998, A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280, J Cell Biol, 140, 1241, 10.1083/jcb.140.5.1241 Sato, 1996, Tissue factor induces migration of cultured aortic smooth muscle cells, Thromb Haemost, 75, 389, 10.1055/s-0038-1650283 Carmeliet, 1998, Tissue factor, Int J Biochem Cell Biol, 30, 661, 10.1016/S1357-2725(97)00121-0 Taubman, 1997, Tissue factor in the pathogenesis of atherosclerosis, Thromb Haemost, 78, 200, 10.1055/s-0038-1657526 Hatekeyama, 1997, Localization and activity of tissue factor in human aortic atherosclerotic lesions, Atherosclerosis, 133, 213, 10.1016/S0021-9150(97)00132-9 Annex, 1995, Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes, Circulation, 91, 619, 10.1161/01.CIR.91.3.619 Losordo, 1992, How does angioplasty work? Serial analysis of human iliac arteries using intravascular ultrasound, Circulation, 86, 1845, 10.1161/01.CIR.86.6.1845 Nath, 1993, Thrombosis of a flexible coil coronary stent: frequency, predictors, and clinical outcome, J Am Col Cardiol, 21, 622, 10.1016/0735-1097(93)90093-G Carrozza, 1993, Complications of directional coronary atherectomy: incidence, causes, and management, Am J Cardiol, 72, 47E, 10.1016/0002-9149(93)91038-J Channon, 1997, Modulation of tissue factor protein expression in experimental venous bypass grafts, Arterioscler Thromb Vasc Biol, 17, 1313, 10.1161/01.ATV.17.7.1313 Taubman, 1993, Tissue factor regulation in vascular smooth muscle: a summary of studies performed during in vivo and in vitro models, Am J Cardiol, 72, 55C, 10.1016/0002-9149(93)90256-C Smariga, 1982, Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cells, Blood, 60, 140, 10.1182/blood.V60.1.140.140 Mach, 1997, Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis, Proc Natl Acad Sci USA, 1936, 94, 1931, 10.1073/pnas.94.5.1931 Mallett, 1991, A new superfamily of cell surface proteins related to the nerve growth factor receptor, Immunol Today, 12, 220, 10.1016/0167-5699(91)90033-P Smith, 1994, The TNF receptor superfamily of cellular, and viral proteins: activation, costimulation, and death, Cell, 76, 959, 10.1016/0092-8674(94)90372-7 Armitage, 1994, Tumor necrosis factor receptor superfamily members and their ligands, Curr Opin Immunol, 6, 407, 10.1016/0952-7915(94)90119-8 Foy, 1996, Immune regulation by CD40 and its ligand GP39, Annu Rev Immunol, 14, 591, 10.1146/annurev.immunol.14.1.591 Van Kooten, 1996, CD40-CD40 ligand: a multifunctional receptor-ligand pair, Adv Immunol, 61, 1, 10.1016/S0065-2776(08)60865-2 Grewal, 1998, CD40, and CD154 in cell-mediated immunity, Annu Rev Immunol, 16, 111, 10.1146/annurev.immunol.16.1.111 Noelle, 1992, A 39-kD protein on activated helper T cells binds CD40, and transduces the signal for cognate activation of B cells, Proc Natl Acad Sci USA, 98, 6550, 10.1073/pnas.89.14.6550 Lederman, 1992, Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help), J Exp Med, 175, 1091, 10.1084/jem.175.4.1091 Laman, 1996, Functions of CD40 and its ligand, gp39 (CD40L), Crit Rev Immunol, 16, 59, 10.1615/CritRevImmunol.v16.i1.40 Noelle, 1998, CD40, and its ligand in cell-mediated immunity, Agents Actions Suppl, 49, 17 Schonbeck, 1997, Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?, Circ Res, 81, 448, 10.1161/01.RES.81.3.448 Mazzei, 1995, Recombinant soluble trimeric CD40 ligand is biologically active, J Biol Chem, 270, 7025, 10.1074/jbc.270.13.7025 Pullen, 1999, High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization, Biochemistry, 38, 10168, 10.1021/bi9909905 Schonbeck, 1999, Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo, J Exp Med, 189, 843, 10.1084/jem.189.5.843 Libby, 1983, Culture of quiescent arterial smooth muscle cells in a defined serum-free medium, J Cell Physiol, 115, 217, 10.1002/jcp.1041150217 Marmur, 1996, Identification of active tissue factor in human coronary atheroma, Circulation, 94, 1226, 10.1161/01.CIR.94.6.1226 Moreno, 1996, Macrophages, smooth muscle cells, and tissue factor in unstable angina, Circulation, 94, 3090, 10.1161/01.CIR.94.12.3090 Mach, 1997, Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor, Circulation, 96, 396, 10.1161/01.CIR.96.2.396 Moreno, 1994, Macrophage infiltration in acute coronary syndromes: implications for plaque rupture, Circulation, 90, 775, 10.1161/01.CIR.90.2.775 Schecter, 1997, Tissue factor expression in human arterial smooth muscle cells: TF is present in three cellular pools after growth factor stimulation, J Clin Invest, 100, 2276, 10.1172/JCI119765 Henn, 1998, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, 391, 591, 10.1038/35393 Wagner, 1994, Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis, Eur J Immunol, 24, 3148, 10.1002/eji.1830241235 Karmann, 1995, CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression, Proc Natl Acad Sci USA, 92, 4342, 10.1073/pnas.92.10.4342 Hollenbaugh, 1995, Expression of functional CD40 by vascular endothelial cells, J Exp Med, 182, 33, 10.1084/jem.182.1.33 Kiener, 1995, Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes, J Immunol, 155, 4917, 10.4049/jimmunol.155.10.4917 Kato, 1996, Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction, J Immunol, 156, 3932, 10.4049/jimmunol.156.10.3932 Mach, 1999, T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation, Am J Pathol, 154, 229, 10.1016/S0002-9440(10)65269-8 Schonbeck, 1997, Ligation of CD40 activates interleukin 1β-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1β, J Biol Chem, 272, 19569, 10.1074/jbc.272.31.19569 Mach, 1998, Reduction of atherosclerosis in mice by inhibition of CD40 signalling, Nature, 394, 200, 10.1038/28204 Briscoe, 1998, Interactions between T lymphocytes and endothelial cells in allograft rejection, Curr Opin Immunol, 10, 525, 10.1016/S0952-7915(98)80218-5 Gaweco, 1999, CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection, Liver Transpl Surg, 5, 1, 10.1002/lt.500050108 Slupsky, 1998, Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40, Thromb Haemost, 80, 1008, 10.1055/s-0037-1615402 Zhou, 1998, CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity, Thromb Haemost, 79, 1025, 10.1055/s-0037-1615114 Miller, 1998, CD40L-CD40 interactions regulate endothelial cell surface tissue factor, and thrombomodulin expression, J Leukoc Biol, 63, 373, 10.1002/jlb.63.3.373 Gregory, 1985, Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones, J Clin Invest, 76, 2440, 10.1172/JCI112260 Geng, 1995, Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme, Am J Pathol, 147, 251 Farb, 1996, Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death, Circulation, 93, 1354, 10.1161/01.CIR.93.7.1354 van der Wal, 1994, Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology, Circulation, 89, 36, 10.1161/01.CIR.89.1.36 Caplice, 1998, Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity, Circulation, 98, 1051, 10.1161/01.CIR.98.11.1051